Stem Cells and Organoids: A Paradigm Shift in Preclinical Models Toward Personalized Medicine
<b>Background/Objectives</b>: Human pluripotent stem cells (hPSCs) and organoid technologies are transforming pharmaceutical research by providing models that more accurately reflect human physiology, genetic variability, and disease mechanisms. This review aims to assess how these syste...
Saved in:
Main Authors: | Eleanor Luce, Jean-Charles Duclos-Vallee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/18/7/992 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of BMPR2 Mutation in Lung Organoid Differentiation
by: Simin Jiang, et al.
Published: (2025-07-01) -
Organoids for tissue repair and regeneration
by: Biao Yu, et al.
Published: (2025-08-01) -
Constructing a research model for liver regeneration by using hepatocyte-like organoid derived from human pluripotent stem cells
by: WANG Chenxi, YANG Shuchun, JIA Yuyan, HUANG Yue
Published: (2025-05-01) -
Human cerebral organoids: Complex, versatile, and human-relevant models of neural development and brain diseases
by: Raquel Coronel, et al.
Published: (2026-03-01) -
Organoids pharmacology and toxicology
by: Jie Sun, et al.
Published: (2025-09-01)